secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marpai, Inc. (MRAI)
CIK:        0001844392
Form:       8-K
Filed at:   2025-05-14T23:59:59+00:00
Accession:  0001213900-25-043324
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Marpai Q1 2025 revenue $5.4M down 27% YoY; operating loss narrows 45% to $2.3M
------------------------------------------------------------------------------

- Net revenue $5.4M, down $2.0M (27%) vs Q1 2024; operating expenses cut 33% to $7.7M.
- Operating loss improved 45% to $2.3M; net loss $3.1M improved 29% vs prior year.
- EPS of ($0.21), improvement of $0.25 per share year over year.
- Unrestricted cash $0.7M at quarter end; CEO targets profitability and positive cash flow by end of 2025.
- Key initiatives: launch of Healthcare Management tool with Empara, MarpaiRx advancements, new COO Dallas Scrip onboarded.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844392/000121390025043324/0001213900-25-043324-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844392/000121390025043324/ea0242151-8k_marpai.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-043324

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer